VILLA, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.645
AS - Asia 13.697
EU - Europa 12.231
SA - Sud America 2.214
AF - Africa 349
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 24
Totale 62.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.166
SG - Singapore 4.434
GB - Regno Unito 3.687
CN - Cina 3.502
IT - Italia 1.950
BR - Brasile 1.725
HK - Hong Kong 1.577
VN - Vietnam 1.502
SE - Svezia 1.272
DE - Germania 1.242
FI - Finlandia 899
PL - Polonia 714
RU - Federazione Russa 596
TR - Turchia 561
UA - Ucraina 547
FR - Francia 478
KR - Corea 425
BD - Bangladesh 404
IN - India 293
BG - Bulgaria 268
CA - Canada 214
ID - Indonesia 213
AR - Argentina 173
MX - Messico 129
NL - Olanda 114
JP - Giappone 111
ZA - Sudafrica 103
IQ - Iraq 96
AE - Emirati Arabi Uniti 78
ES - Italia 68
PK - Pakistan 68
EC - Ecuador 67
BE - Belgio 58
CO - Colombia 56
LT - Lituania 53
EG - Egitto 52
IE - Irlanda 52
MA - Marocco 52
AT - Austria 49
VE - Venezuela 49
CL - Cile 45
MY - Malesia 44
UZ - Uzbekistan 44
KE - Kenya 41
PH - Filippine 39
SA - Arabia Saudita 36
NP - Nepal 35
JO - Giordania 33
PE - Perù 31
PY - Paraguay 30
BZ - Belize 26
DZ - Algeria 26
AU - Australia 25
CZ - Repubblica Ceca 25
TN - Tunisia 23
UY - Uruguay 21
RO - Romania 19
CR - Costa Rica 18
IL - Israele 18
TH - Thailandia 18
AZ - Azerbaigian 17
CH - Svizzera 17
IR - Iran 17
EU - Europa 16
AL - Albania 15
BO - Bolivia 15
DK - Danimarca 15
DO - Repubblica Dominicana 15
LB - Libano 15
JM - Giamaica 14
RS - Serbia 14
GE - Georgia 13
HN - Honduras 13
KZ - Kazakistan 13
QA - Qatar 13
HU - Ungheria 12
OM - Oman 12
BH - Bahrain 11
ET - Etiopia 11
LV - Lettonia 10
PA - Panama 10
SK - Slovacchia (Repubblica Slovacca) 10
GT - Guatemala 9
NZ - Nuova Zelanda 9
SI - Slovenia 9
TW - Taiwan 9
BY - Bielorussia 8
SN - Senegal 8
TT - Trinidad e Tobago 8
AO - Angola 6
KG - Kirghizistan 6
AM - Armenia 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
PT - Portogallo 5
SV - El Salvador 5
CY - Cipro 4
GA - Gabon 4
MN - Mongolia 4
NI - Nicaragua 4
Totale 62.105
Salva come PNG Salva come JPEG
Città #
Fairfield 3.544
Ashburn 3.356
Santa Clara 2.830
Singapore 2.723
Southend 2.383
Woodbridge 1.967
Houston 1.910
Chandler 1.659
Hong Kong 1.528
Seattle 1.353
Wilmington 1.214
Cambridge 1.120
Ann Arbor 1.067
Jacksonville 1.020
Hefei 966
New York 901
San Jose 899
Dearborn 789
Nyköping 739
Helsinki 734
London 710
Warsaw 687
Beijing 611
Los Angeles 569
Chicago 525
Modena 511
Ho Chi Minh City 477
Council Bluffs 467
The Dalles 401
Izmir 377
Hanoi 362
Seoul 338
San Diego 317
Princeton 267
Sofia 259
Grafing 255
Lauterbourg 232
Milan 211
Buffalo 208
Shanghai 197
Salt Lake City 194
Eugene 183
Moscow 169
São Paulo 167
Jersey City 157
Jakarta 154
Dallas 138
Munich 133
Redwood City 130
Des Moines 113
Orem 101
Tampa 97
Columbus 95
Tokyo 93
Frankfurt am Main 89
Bremen 87
Elk Grove Village 82
Phoenix 70
Atlanta 69
Boardman 66
Bologna 65
Rio de Janeiro 64
Brooklyn 61
Rome 61
Da Nang 60
Bupyeong-gu 59
Redondo Beach 59
Guangzhou 58
Brussels 54
Montreal 54
Haiphong 53
Chennai 52
Johannesburg 52
San Mateo 48
Denver 47
Dublin 47
Falls Church 47
Norwalk 47
Toronto 46
Miano 45
Belo Horizonte 43
Philadelphia 43
Nanjing 42
Kent 41
Nuremberg 41
Tashkent 41
Baghdad 40
Mexico City 39
Sterling 37
Fremont 34
Nairobi 34
Naples 33
San Francisco 33
Vancouver 32
Brasília 31
Dhaka 31
Paris 31
Stockholm 30
Amman 29
Biên Hòa 29
Totale 44.863
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 705
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 623
AISF position paper on liver disease and pregnancy 592
Non-alcoholic steatohepatitis and liver transplantation 521
Intestinal/multivisceral transplantation: University of Modena experience 451
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 444
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 438
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 436
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 433
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 413
Orthogonal polarization spectral imaging: A new tool in morphologic surveillance in intestinal transplant recipients 394
Coagulopathy in liver diseases: complication or therapy? 390
Outcomes after adult isolated small bowel transplantation: experience from a single European centre. 389
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 388
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 384
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 382
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 380
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 377
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 375
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 371
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 359
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 353
Alcohol and Hepatitis B Virus Infection 348
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 347
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 347
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 341
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial 339
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy 331
Fulminant onset of spontaneous bacterial peritonitis. 326
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 324
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 320
Variant estrogen receptors and their role in liver disease 315
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 314
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 314
Hepatic allograft salvage with early Doppler ultrasound diagnosis of acute vena cava thrombosis 312
High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: Long term results of a prospective randomized trial 308
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 307
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 307
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 306
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 305
Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study 298
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 298
Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma 297
Ethanol-induced increase in cytosolic estrogen receptors in human male liver: a possible explanation for biochemical feminization in chronic liver disease due to alcohol. 297
From current status to optimization of HCV treatment: Recommendations from an expert panel 294
Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems 293
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 293
Missed treatment in an Italian HBV infected patients cohort: HBV RER 293
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 293
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation 291
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 290
Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. 290
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 289
Clinical staging systems for hepatocellular carcinoma: Comparison with estrogen receptor classification 287
Obese zebrafish: A small fish for a major human health condition 287
HEPATITIS-C VIRUS TESTING IN PRIMARY BILIARY-CIRRHOSIS 286
Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. 286
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 286
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 285
Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. 284
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 284
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 283
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 281
HEPATITIS-B VIRUS SPECIFIC TRANSCRIPTS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 279
Influence of age and gender before and after liver transplantation 273
Flow-dependent shear stress affects the biological properties of pericyte-like cells isolated from human dental pulp 272
Hepatocellular carcinoma - Role of estrogen receptors in the liver 272
Gastrointestinal endoscopy and HBV infection: no evidence for a causal relationship. A prospective controlled study. 272
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 271
EVIDENCE FOR HEPATITIS-B VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C WITH AND WITHOUT SEROLOGICAL MARKERS OF HEPATITIS-B 271
Massive GI bleeding due to accidental ASA inhalation. 270
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant 270
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 269
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 269
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 268
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 268
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 267
Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis 265
Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. 264
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 264
Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C. 264
Estrogens receptors and oxidative damage in the liver 262
Sex hormones and liver cancer 261
No inflammation? No cancer! Clear HBV early and live happily. 259
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 259
BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence 259
"Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not? 258
Treatment of nonalcoholic steatohepatitis in adults: present and future 257
Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis. 254
Androgen receptor alterations in hepatocarcinogenesis. 253
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors 252
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study 252
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 252
HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 250
PRESENCE OF HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 249
Anticoagulation in cirrhosis: a new paradigm? 249
Experimental hepatology applied to stem cells 249
Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis 248
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results 248
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury 247
Totale 31.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021307 0 0 0 0 0 0 0 0 0 0 0 307
2021/20224.917 334 550 347 283 133 262 508 267 502 407 847 477
2022/20234.584 561 524 353 437 502 712 62 421 537 45 202 228
2023/20242.629 117 177 210 279 458 221 239 327 67 54 155 325
2024/202510.264 337 99 139 732 2.050 1.521 613 678 1.466 655 845 1.129
2025/202620.242 1.243 717 1.580 2.344 2.980 2.666 2.271 1.052 1.824 1.737 1.596 232
Totale 62.621